[go: up one dir, main page]

AUPQ547100A0 - Liver selective therapy - Google Patents

Liver selective therapy

Info

Publication number
AUPQ547100A0
AUPQ547100A0 AUPQ5471A AUPQ547100A AUPQ547100A0 AU PQ547100 A0 AUPQ547100 A0 AU PQ547100A0 AU PQ5471 A AUPQ5471 A AU PQ5471A AU PQ547100 A AUPQ547100 A AU PQ547100A AU PQ547100 A0 AUPQ547100 A0 AU PQ547100A0
Authority
AU
Australia
Prior art keywords
selective therapy
liver selective
liver
therapy
selective
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AUPQ5471A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Howard J Smith and Associates Pty Ltd
Original Assignee
Howard J Smith and Associates Pty Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Howard J Smith and Associates Pty Ltd filed Critical Howard J Smith and Associates Pty Ltd
Priority to AUPQ5471A priority Critical patent/AUPQ547100A0/en
Publication of AUPQ547100A0 publication Critical patent/AUPQ547100A0/en
Priority to KR1020027005700A priority patent/KR20020063174A/en
Priority to PCT/AU2000/001337 priority patent/WO2001032162A1/en
Priority to IL14942200A priority patent/IL149422A0/en
Priority to CN00815452A priority patent/CN1387430A/en
Priority to JP2001534367A priority patent/JP2003513036A/en
Priority to NZ518707A priority patent/NZ518707A/en
Priority to EP00972466A priority patent/EP1242064A4/en
Priority to CA002389616A priority patent/CA2389616A1/en
Priority to AU11190/01A priority patent/AU773452B2/en
Priority to AU2001229889A priority patent/AU2001229889A1/en
Priority to PCT/AU2001/000105 priority patent/WO2001058490A1/en
Priority to NO20021976A priority patent/NO20021976L/en
Priority to US10/137,444 priority patent/US20020160044A1/en
Priority to US11/819,279 priority patent/US20080242732A1/en
Priority to US11/819,278 priority patent/US20070269513A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/138—Aryloxyalkylamines, e.g. propranolol, tamoxifen, phenoxybenzamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A61K31/366—Lactones having six-membered rings, e.g. delta-lactones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Emergency Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AUPQ5471A 1999-11-03 2000-02-07 Liver selective therapy Abandoned AUPQ547100A0 (en)

Priority Applications (16)

Application Number Priority Date Filing Date Title
AUPQ5471A AUPQ547100A0 (en) 2000-02-07 2000-02-07 Liver selective therapy
AU11190/01A AU773452B2 (en) 1999-11-03 2000-11-01 Liver selective therapy
NZ518707A NZ518707A (en) 1999-11-03 2000-11-01 Liver selective therapy
CA002389616A CA2389616A1 (en) 1999-11-03 2000-11-01 Liver selective therapy
IL14942200A IL149422A0 (en) 1999-11-03 2000-11-01 Oral pharmaceutical compositions for liver therapy
CN00815452A CN1387430A (en) 1999-11-03 2000-11-01 Liver selective therapy
JP2001534367A JP2003513036A (en) 1999-11-03 2000-11-01 Liver selective treatment
KR1020027005700A KR20020063174A (en) 1999-11-03 2000-11-01 Liver selective therapy
EP00972466A EP1242064A4 (en) 1999-11-03 2000-11-01 Liver selective therapy
PCT/AU2000/001337 WO2001032162A1 (en) 1999-11-03 2000-11-01 Liver selective therapy
PCT/AU2001/000105 WO2001058490A1 (en) 2000-02-07 2001-02-07 Liver-selective chemotherapy
AU2001229889A AU2001229889A1 (en) 2000-02-07 2001-02-07 Liver-selective chemotherapy
NO20021976A NO20021976L (en) 1999-11-03 2002-04-25 Selective liver therapy
US10/137,444 US20020160044A1 (en) 1999-11-03 2002-05-03 Liver selective drug therapy
US11/819,279 US20080242732A1 (en) 1999-11-03 2007-06-26 Liver selective drug therapy
US11/819,278 US20070269513A1 (en) 1999-11-03 2007-06-26 Liver selective drug therapy

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
AUPQ5471A AUPQ547100A0 (en) 2000-02-07 2000-02-07 Liver selective therapy

Publications (1)

Publication Number Publication Date
AUPQ547100A0 true AUPQ547100A0 (en) 2000-03-02

Family

ID=3819591

Family Applications (1)

Application Number Title Priority Date Filing Date
AUPQ5471A Abandoned AUPQ547100A0 (en) 1999-11-03 2000-02-07 Liver selective therapy

Country Status (2)

Country Link
AU (1) AUPQ547100A0 (en)
WO (1) WO2001058490A1 (en)

Also Published As

Publication number Publication date
WO2001058490A1 (en) 2001-08-16

Similar Documents

Publication Publication Date Title
AU2001252135A1 (en) Therapeutic agents
AU2002222853A1 (en) Therapeutic compounds
AU2001262847A1 (en) Language-understanding
AU2001292739A1 (en) 1-oxorapamycins
AU2001288040A1 (en) Homeostasis-maintaining agents
AU2001254546A1 (en) Aminopiperidines
AU2000267458A1 (en) Hypercomputer
AU2002214284A1 (en) Anti-helicobacterial agents
AU2001220246A1 (en) Neckphone
AU2001239310A1 (en) Decahydro-isoquinolines
AU2001258349A1 (en) Bisacylguanidine
AU2001279754A1 (en) Indoloquinazolinones
AU2001290931A1 (en) Ski-snowboard
AU2001285886A1 (en) 2-guanidino-4-aryl-quinazoline
AU2001258924A1 (en) Microsatellite-aflp
AU2001293852A1 (en) Sulfonylguanidine
AU2001266176A1 (en) Methods
AU2001281921A1 (en) Bdellosomes
AU2001273903A1 (en) Therapeutic agents
EP1242064A4 (en) Liver selective therapy
AU2001291876A1 (en) Triazolo-epothilones
AU2001246864A1 (en) Hypotensors
AU2001226668A1 (en) Crankshaft-starter-generator
AU2001262711A1 (en) Cytoprotectors
AU2001275696A1 (en) Therapeutic agent

Legal Events

Date Code Title Description
NAA1 Application designating australia and claiming priority from australian document

Ref document number: 1119001

Country of ref document: AU

NAA1 Application designating australia and claiming priority from australian document

Ref document number: 2988901

Country of ref document: AU